期刊文献+

低氧诱导因子在肿瘤干细胞介导的肿瘤发生发展中的作用 被引量:1

Role of hypoxia-induced factors in cancer development mediated by cancer stem cells
下载PDF
导出
摘要 低氧及低氧诱导因子(HIFs)是肿瘤干细胞、转移起始细胞及其分化后代在肿瘤发生发展过程中,能够适应氧气和营养物质缺乏的主要调节因子。在白血病、胶质母细胞瘤、黑色素瘤、前列腺癌、乳腺癌、胰腺癌等肿瘤中均发现HIFs的表达上调,尤其集中表达在低氧区域。活化的HIFs可以诱导多种干性及多药耐药等基因的表达,对肿瘤及干性介导的肿瘤细胞的自我更新、能量代谢改变、侵袭转移、血管生成以及治疗抵抗均起着重要作用。因此,研究HIFs分子在干细胞介导的不同肿瘤细胞中的靶向调节作用和代谢通路的改变,将为肿瘤的靶向治疗提供新线索。 Hypoxia and hypoxia-induced factors (HIFs) are main regulators for tumor stem cells, metastasis-initiating cells and their differentiated progenies to adapt to the environment which lacks oxygen and nutrient in the process of cancer development. HIFs are up-regulated in many tumors, including leukemia, glioblastoma, melanoma, prostate cancer, breast cancer and pancreatic cancer, in where they are especially highly expressed in hypoxic regions. HIFs activation can induce expression of numerous stem cell related genes and multidrug resistance genes, which may play important roles in tumour and stem cell-mediated self-renewing, energy metabolism alternation, invasion, metastasis, angiogenesis and treatment resis-tance of neoplastic cells. Consequently, it will provide new clues for cancer therapy after investigating the role of HIFs in tar-geted regulation and metabolic pathway modulation in various stem cell-mediated tumor cells.
出处 《天津医药》 CAS 2015年第6期690-693,共4页 Tianjin Medical Journal
基金 国家自然科学基金资助项目(81102472 81373427) 辽宁省高等学校杰出青年学者成长计划项目(LJQ2014084) 辽宁省大学生创新创业训练计划项目(201410159040 201410159012)
关键词 肿瘤干细胞 低氧诱导因子 代谢通路 靶向治疗 neoplastic stem cells hypoxia-induced factors(HIFs) metabolic pathway targeted therapy
  • 相关文献

参考文献2

二级参考文献15

  • 1DeSantis C, Siegel R, Bandi P, et al. Breast cancer statistics[J].CA Cancer J Clin, 2011, 61(6): 409-418.
  • 2de Mascarel I, MacGrogan G, Mathoulin-Plissier S, et al. Breast ductal carcinoma in situ with microinvasion: a definition supported by a long-term study of 1248 serially sectioned ductal carcinomas[J]. Cancer, 2002, 94(8): 2134-2142.
  • 3Yu KD, Wu LM, Liu GY, et al. Different distribution of breast cancer subtypes in breast ductal carcinoma in situ (DCIS), DCIS with microinvasion, and DCIS with invasion component[J]. Ann Surg Oncol, 2011, 18(5): 1342-1348.
  • 4Hammond ME, Hayes DF, Dowsett M, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistoehemical testing of estrogen and progesterone receptors in breast cancer (unabridged version) [J]. Arch Pathol Lab Med, 2010, 134(7): e48-e72.
  • 5Liu C, Zhang H, Shuang C, et al. Alternations of ER, PR, HER-2/neu, and P53 protein expression in ductal breast carcinomas and clinical implications[J]. Med Oncol, 2010, 27(3): 747-752.
  • 6Zhang W, Gao EL, Zhou YL, et al. Different distribution of breast ductal carcinoma in situ, ductal carcinoma in situ with microinvasion, and invasion breast cancer[J]. World J Surg Oncol, 2012, 10: 262.
  • 7Kurose K, Hoshaw-Woodard S, Aderinka A, et al. Genetic model of multi-step breast carcinogenesis involving the epithelium and stroma:clues to tumor-microenvirnment interactions[J]. Hum Mol Genet, 2001, 10(18): 1907-1913.
  • 8Olsson N, Carlsson P, James P, et al. Grading breast cancer tissues using molecular portraits [J]. Mol Cell Proteomics, 2013, 12(12): 3612-3623.
  • 9Sofi GN, Sofi JN, Nadeem R, et al. Estrogen receptor and progesterone receptor status in breast cancer in relation to age, histological grade, size of lesion and lymph node involvement[J]. Asian PacJ Cancer Prey, 2012, 13(10): 5047-5052.
  • 10Sotiriou C, Wirapati P, Loi S, et al. Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis[J]. J Natl Cancer Inst, 2006, 98(4): 262-272.

共引文献25

同被引文献18

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部